Efficacy and safety of oral 5‐ FU ‐based adjuvant chemotherapy for geriatric patients with colorectal cancer: Integrated analysis of seven clinical trials conducted at the Japanese Foundation for Multidisciplinary Treatment of Cancer
Colorectal Disease · 2025
DOI: 10.1111/codi.70317 ↗At a glance
Journal article in Colorectal Disease, 2025. Written by Nobuaki Hoshino and 13 co-authors. Institution: Department of Surgery, Kyoto University Graduate School of Medicine, Kyoto, Japan. Major MEDLINE topics: Colorectal Neoplasms, Fluorouracil, Antimetabolites, Antineoplastic. 35 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: The Japanese Foundation for Multidisciplinary Treatment of Cancer.
Topics: Onkologische Pflege
Abstract (original language)
Background
Adjuvant chemotherapy after radical resection is recommended for patients with high‐risk Stages II and III colorectal cancer (CRC). However, the efficacy and safety of adjuvant chemotherapy in geriatric patients require elucidation.
Methods
We analysed data from seven clinical trials conducted by the Japanese Foundation for the Multidisciplinary Treatment of Cancer. Survival curves were estimated using the Kaplan–Meier method and compared using the log‐rank test. Survival analysis was performed using a Cox proportional hazards model.
Results
This study included 7756 non‐geriatric (
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Surgery, Kyoto University Graduate School of Medicine, Kyoto, Japan.
- Department of Gastroenterological Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan.
- Department of Biostatistics, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
- Department of Surgery, Yokohama City University, Yokohama, Japan.
- Department of Minimally Invasive Surgical and Medical Oncology, Fukushima Medical University, Fukushima, Japan.
- Data Science Office, Clinical Research Promotion Center, The University of Tokyo Hospital, Tokyo, Japan.
ORCID profiles: Nobuaki Hoshino
Funding
- The Japanese Foundation for Multidisciplinary Treatment of Cancer
Cite
APA
Hoshino, N., Kanda, M., Oba, K., Aoyama, T., Honda, M., Kashiwabara, K., Maeda, H., Mayanagi, S., Muto, M., Tanaka, K., Yamagishi, H., Sakamoto, J., Obama, K., & Yoshikawa, T. (2025). Efficacy and safety of oral 5‐ FU ‐based adjuvant chemotherapy for geriatric patients with colorectal cancer: Integrated analysis of seven clinical trials conducted at the Japanese Foundation for Multidisciplinary Treatment of Cancer. Colorectal Disease. https://doi.org/10.1111/codi.70317
Vancouver
Hoshino N, Kanda M, Oba K, Aoyama T, Honda M, Kashiwabara K, et al. Efficacy and safety of oral 5‐ FU ‐based adjuvant chemotherapy for geriatric patients with colorectal cancer: Integrated analysis of seven clinical trials conducted at the Japanese Foundation for Multidisciplinary Treatment of Cancer. Colorectal Disease. 2025. doi:10.1111/codi.70317
BibTeX
@article{Hoshino2025,
author = {Hoshino, Nobuaki and Kanda, Mitsuro and Oba, Koji and Aoyama, Toru and Honda, Michitaka and Kashiwabara, Kosuke and Maeda, Hiromichi and Mayanagi, Shuhei and Muto, Masaru and Tanaka, Kenji and Yamagishi, Hisakazu and Sakamoto, Junichi and Obama, Kazutaka and Yoshikawa, Takaki},
title = {Efficacy and safety of oral 5‐ FU ‐based adjuvant chemotherapy for geriatric patients with colorectal cancer: Integrated analysis of seven clinical trials conducted at the Japanese Foundation for Multidisciplinary Treatment of Cancer},
journal = {Colorectal Disease},
year = {2025},
doi = {10.1111/codi.70317}
}
EUVIMED